Dr. Guyguy Manangama

Stories

DR Congo tests Zaire-strain Ebola vaccine against Bundibugyo outbreak

Overseeing the BRAVO vaccination study

Congo's frontline health workers are getting the only Ebola vaccine available at scale, even though it was built for a different virus. Since September 19, the BRAVO study has been vaccinating 20,000 workers in Ituri and North Kivu to test whether Ervebo protects against the Bundibugyo strain.

Updated 33 minutes ago

Notable Quotes

Although ERVEBO was not originally developed to protect against Bundibugyo, preliminary data suggest that it may offer some degree of protection against the virus. In a race against time such as the one the DRC is currently facing, we must use every tool available to us.

from DR Congo tests Zaire-strain Ebola vaccine against Bundibugyo outbreak · Updated 33 minutes ago

It is important to stress that this vaccine will not end the current outbreak. However, it may offer additional protection to those most exposed.

from DR Congo tests Zaire-strain Ebola vaccine against Bundibugyo outbreak · Updated 33 minutes ago